BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for ...
European Medical Journal

Machine Learning Supports Radiology Lung Cancer Screening

A machine learning lung cancer risk prediction model outperformed logistic regression, supporting improved risk assessment and more efficient radiology based lung cancer screening.
Hosted on MSN

Machine learning models can predict urgent care eeds for patients with non–small cell lung cancer

A new study published in JCO Clinical Cancer Informaticsdemonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with ...
ascopubs.org

Validation of LungFlag Lean machine-learning model to identify individuals with lung cancer using multinational data.

†PLCO and LFL (p <.05). ††LF and LFL (p <.05). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.

Deep learning model helps detect lung tumors on CT scans

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published today in Radiology. The findings of the study could have important implications for lung ...
PharmTech

Integrating AI and Machine Learning in Drug Discovery and Development

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

BioMark Diagnostics, Inc.: BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for early ...
EurekAlert!

Deep learning model helps detect lung tumors on CT

Model and clinical segmentation examples. (A) 71-year-old female with non-small cell lung cancer (NSCLC) from the internal test set. (B) 87-year-old male with NSCLC from the external test set. Both ...